Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Connecting aging biology and inflammation in the omics era
Keenan A. Walker, … , David M. Wilson III, Luigi Ferrucci
Keenan A. Walker, … , David M. Wilson III, Luigi Ferrucci
Published July 15, 2022
Citation Information: J Clin Invest. 2022;132(14):e158448. https://doi.org/10.1172/JCI158448.
View: Text | PDF
Review Series

Connecting aging biology and inflammation in the omics era

  • Text
  • PDF
Abstract

Aging is characterized by the accumulation of damage to macromolecules and cell architecture that triggers a proinflammatory state in blood and solid tissues, termed inflammaging. Inflammaging has been implicated in the pathogenesis of many age-associated chronic diseases as well as loss of physical and cognitive function. The search for mechanisms that underlie inflammaging focused initially on the hallmarks of aging, but it is rapidly expanding in multiple directions. Here, we discuss the threads connecting cellular senescence and mitochondrial dysfunction to impaired mitophagy and DNA damage, which may act as a hub for inflammaging. We explore the emerging multi-omics efforts that aspire to define the complexity of inflammaging — and identify molecular signatures and novel targets for interventions aimed at counteracting excessive inflammation and its deleterious consequences while preserving the physiological immune response. Finally, we review the emerging evidence that inflammation is involved in brain aging and neurodegenerative diseases. Our goal is to broaden the research agenda for inflammaging with an eye on new therapeutic opportunities.

Authors

Keenan A. Walker, Nathan Basisty, David M. Wilson III, Luigi Ferrucci

×

Figure 1

Interplay between cellular senescence, mitochondrial dysfunction, and the aging immune system.

Options: View larger image (or click on image) Download as PowerPoint
Interplay between cellular senescence, mitochondrial dysfunction, and th...
During aging, increasing dysfunctional mitochondria contribute to inflammation through several pathways and interact with other hallmarks of aging such as cellular senescence and autophagy. Mitochondrial-derived damage-associated molecular patterns (mtDAMPs) accumulate in the cytosol, including mitochondrial DNA (mtDNA), oxidized mtDNA (ox-mtDNA), and cardiolipin. Accumulation of mtDAMPs leads to downstream production of inflammatory cytokines, type I interferons (IFNs), and chemokines via intracellular pattern recognition receptors to activate an immune response. The collective secretion of mtDAMPs, IFNs, cytokines, and chemokines into the extracellular environment contributes to inflammaging. With age, an increasing mitochondrial dysfunction and production of ROS lead to increased levels of senescent cells, which accumulate naturally with age and in response to multiple stimuli. The accumulation of senescent cells and the SASP increases the release of bioactive molecules, including cytokines, recruitment factors, and DAMPs, into circulation, thereby driving inflammaging. In turn, the accumulation of senescent lymphocytes in the aging immune system further propagates cellular senescence in peripheral tissues.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts